Andrew Hertler
Impact in
- Biotechnology top 5%
- Transgenic Plants and Applications
- Immunology top 10%
- Toxin Mechanisms and Immunotoxins
Papers in
-
- Toxin Mechanisms and Immunotoxins 9
- Galectins and Cancer Biology 1
-
- Transgenic Plants and Applications 7
- Co-authors
- Arthur E. Frankel (8 shared papers)David M. Schlossman (4 shared papers)Michael J. Borowitz (2 shared papers)Pierre Casellas (2 shared papers)F. K. Jansen (2 shared papers)D A Withers (1 shared paper)S. A. Johnston (1 shared paper)Philip Welsh (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Cancer treatment and research (2 papers)Molecular and Cellular Biology (2 papers)Journal of the National Comprehensive Cancer Network (1 paper)Clinics in Geriatric Medicine (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
Andrew Hertler
17 papers receiving 413 citations
Peers
Comparison fields: 5 of 63
- Biotechnology 192
- Immunology 287
- Genetics 61
- Radiology, Nuclear Medicine and Imaging 98
- Hematology 43
Countries citing papers authored by Andrew Hertler
This map shows the geographic impact of Andrew Hertler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Hertler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Hertler more than expected).
Fields of papers citing papers by Andrew Hertler
This network shows the impact of papers produced by Andrew Hertler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Hertler. The network helps show where Andrew Hertler may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Hertler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 90 | |
| 2 | A phase I study of T101-ricin A chain immunotoxin in refractory chronic lymphocytic leukemia. | 1988 | 58 |
| 3 | 1989 | 54 | |
| 4 | 1989 | 53 | |
| 5 | 1987 | 32 | |
| 6 | 1995 | 31 | |
| 7 | 1997 | 26 | |
| 8 | 2019 | 25 | |
| 9 | 1989 | 15 | |
| 10 | 2020 | 11 | |
| 11 | 1988 | 10 | |
| 12 | 1988 | 5 | |
| 13 | 1991 | 5 | |
| 14 | 1986 | 5 | |
| 15 | 1987 | 4 | |
| 16 | 1990 | 3 | |
| 17 | 2012 | 1 | |
| 18 | 2023 | 0 |
About Andrew Hertler
Andrew Hertler is a scholar working on Immunology, Biotechnology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 18 papers that have together received 428 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (9 papers), Transgenic Plants and Applications (7 papers), Plant tissue culture and regeneration (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Economic and Financial Impacts of Cancer (2 papers), Breast Cancer Treatment Studies (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Biotechnology (192 citations), Immunology (287 citations), Genetics (61 citations), Radiology, Nuclear Medicine and Imaging (98 citations) and Hematology (43 citations). Andrew Hertler has collaborated with scholars based in United States and France. Frequent co-authors include Arthur E. Frankel, David M. Schlossman, Michael J. Borowitz, Pierre Casellas, F. K. Jansen, D A Withers, S. A. Johnston, Philip Welsh, H. Blythman and Guy Laurent. Their work appears in journals such as Journal of Clinical Oncology, Cancer treatment and research, Molecular and Cellular Biology, Journal of the National Comprehensive Cancer Network and Clinics in Geriatric Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.